trial · primary record
GSK4532990
Non-alcoholic Fatty Liver Disease
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 61 |
| Primary completion | 2025-09-23 |
| Primary endpoint | Predicted Mean Percent Change From Baseline (CFB) in Liver Biopsy-derived HSD17B13 Protein Expression Levels |
| Registry ID | NCT06104319 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:51.078Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06104319
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.